- Home
- CODX vs PRHI Comparison
CODX vs PRHI Comparison
Compare CODX & PRHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- PRHI
- Stock Information
- Founded
- CODX 2013
- PRHI 2009
- Country
- CODX United States
- PRHI United States
- Employees
- CODX N/A
- PRHI N/A
- Industry
- CODX Medical/Dental Instruments
- PRHI Property-Casualty Insurers
- Sector
- CODX Health Care
- PRHI Finance
- Exchange
- CODX Nasdaq
- PRHI Nasdaq
- Market Cap
- CODX 16.9M
- PRHI 13.7M
- IPO Year
- CODX 2017
- PRHI N/A
- Fundamental
- Price
- CODX $0.39
- PRHI $1.70
- Analyst Decision
- CODX Buy
- PRHI
- Analyst Count
- CODX 2
- PRHI 0
- Target Price
- CODX $2.00
- PRHI N/A
- AVG Volume (30 Days)
- CODX 14.5M
- PRHI 4.4M
- Earning Date
- CODX 11-06-2025
- PRHI 11-12-2025
- Dividend Yield
- CODX N/A
- PRHI N/A
- EPS Growth
- CODX N/A
- PRHI N/A
- EPS
- CODX N/A
- PRHI 2.45
- Revenue
- CODX $1,003,653.00
- PRHI $52,654,000.00
- Revenue This Year
- CODX N/A
- PRHI N/A
- Revenue Next Year
- CODX $31.58
- PRHI N/A
- P/E Ratio
- CODX N/A
- PRHI $0.75
- Revenue Growth
- CODX N/A
- PRHI N/A
- 52 Week Low
- CODX $0.23
- PRHI $0.42
- 52 Week High
- CODX $1.40
- PRHI $2.83
- Technical
- Relative Strength Index (RSI)
- CODX 48.59
- PRHI N/A
- Support Level
- CODX $0.32
- PRHI N/A
- Resistance Level
- CODX $0.41
- PRHI N/A
- Average True Range (ATR)
- CODX 0.04
- PRHI 0.00
- MACD
- CODX -0.01
- PRHI 0.00
- Stochastic Oscillator
- CODX 28.99
- PRHI 0.00
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.